Skip Content
You are currently on the new version of our website. Access the old version .

946 Results Found

  • Article
  • Open Access
12 Citations
2,931 Views
13 Pages

23 November 2021

The activation of the SDF-1/CXCR-4 pathway is crucial for the invasion and metastasis of oral cancer cells. The CXCR-4 positive cells possess stem cell characteristics and express the cancer stem cell marker, CD133, in tumors of colon and pancreas. D...

  • Article
  • Open Access
5,222 Views
12 Pages

Omega-3 Fatty Acids Supplementation Differentially Modulates the SDF-1/CXCR-4 Cell Homing Axis in Hypertensive and Normotensive Rats

  • Luiza Halmenschlager,
  • Alexandre Machado Lehnen,
  • Aline Marcadenti and
  • Melissa Medeiros Markoski

1 August 2017

Background: We assessed the effect of acute and chronic dietary supplementation of ω-3 on lipid metabolism and cardiac regeneration, through its influence on the Stromal Derived Factor-1 (SDF-1) and its receptor (CXCR4) axis in normotensive and hyper...

  • Review
  • Open Access
105 Citations
9,187 Views
16 Pages

Chemokines are chemotactic cytokines that promote cancer growth, metastasis, and regulate resistance to chemotherapy. Stromal cell-derived factor 1 (SDF1) also known as C-X-C motif chemokine 12 (CXCL12), a prognostic factor, is an extracellular homeo...

  • Article
  • Open Access
19 Citations
3,912 Views
15 Pages

Targeting of CXCR4 by the Naturally Occurring CXCR4 Antagonist EPI-X4 in Waldenström’s Macroglobulinemia

  • Lisa Marie Kaiser,
  • Mirja Harms,
  • Daniel Sauter,
  • Vijay P. S. Rawat,
  • Mirco Glitscher,
  • Eberhard Hildt,
  • Daniel Tews,
  • Zachary Hunter,
  • Jan Münch and
  • Christian Buske

16 February 2021

CXCR4 expression and downstream signaling have been identified as key factors in malignant hematopoiesis. Thus, up to 40% of all patients with Waldenström’s macroglobulinemia (WM) carry an activating mutation of CXCR4 that leads to a more aggressive...

  • Feature Paper
  • Article
  • Open Access
9 Citations
3,255 Views
12 Pages

Biological Role of Tumor/Stromal CXCR4-CXCL12-CXCR7 in MITO16A/MaNGO-OV2 Advanced Ovarian Cancer Patients

  • Crescenzo D’Alterio,
  • Anna Spina,
  • Laura Arenare,
  • Paolo Chiodini,
  • Maria Napolitano,
  • Francesca Galdiero,
  • Luigi Portella,
  • Vittorio Simeon,
  • Simona Signoriello and
  • Stefania Scala
  • + 15 authors

6 April 2022

This study investigated the prognostic role of the CXCR4-CXCL12-CXCR7 axis in advanced epithelial ovarian cancer (EOC) patients receiving first-line treatment within the MITO16A/MaNGO-OV2 phase-IV trial. CXCR4-CXCL12-CXCR7 expression was evaluated in...

  • Article
  • Open Access
10 Citations
4,302 Views
19 Pages

CXCR4-CXCL12-CXCR7 and PD-1/PD-L1 in Pancreatic Cancer: CXCL12 Predicts Survival of Radically Resected Patients

  • Crescenzo D’Alterio,
  • Alessandro Giardino,
  • Giosuè Scognamiglio,
  • Giovanni Butturini,
  • Luigi Portella,
  • Giuseppe Guardascione,
  • Isabella Frigerio,
  • Marco Montella,
  • Stefano Gobbo and
  • Stefania Scala
  • + 5 authors

22 October 2022

Pancreatic ductal adenocarcinoma (PDAC) is currently the most deadly cancer. Although characterized by 5–20% of neoplastic cells in the highly fibrotic stroma, immunotherapy is not a valid option in PDAC treatment. As CXCR4-CXCL12 regulates tum...

  • Review
  • Open Access
1 Citations
1,697 Views
21 Pages

The Interleukin-8-CXCR1/2 Axis as a Therapeutic Target in Peritoneal Carcinomatosis

  • Christopher Sherry,
  • Neda Dadgar,
  • Zuqiang Liu,
  • Yong Fan,
  • Kunhong Xiao,
  • Ali H. Zaidi,
  • Vera S. Donnenberg,
  • Albert D. Donnenberg,
  • David L. Bartlett and
  • Patrick L. Wagner

5 September 2025

Peritoneal carcinomatosis (PC) is a late-stage manifestation of abdominopelvic malignancies with poor prognosis and limited treatment options. Unique biochemical mechanisms within the peritoneal cavity play a key role in disease progression and resis...

  • Review
  • Open Access
86 Citations
14,375 Views
17 Pages

The Distinct Roles of CXCR3 Variants and Their Ligands in the Tumor Microenvironment

  • Nathan Reynders,
  • Dayana Abboud,
  • Alessandra Baragli,
  • Muhammad Zaeem Noman,
  • Bernard Rogister,
  • Simone P. Niclou,
  • Nikolaus Heveker,
  • Bassam Janji,
  • Julien Hanson and
  • Andy Chevigné
  • + 1 author

18 June 2019

First thought to orchestrate exclusively leukocyte trafficking, chemokines are now acknowledged for their multiple roles in the regulation of cell proliferation, differentiation, and survival. Dysregulation of their normal functions contributes to va...

  • Article
  • Open Access
31 Citations
3,888 Views
17 Pages

Prognostic Value of CXCR2 in Breast Cancer

  • Florence Boissière-Michot,
  • William Jacot,
  • Julien Fraisse,
  • Sophie Gourgou,
  • Colin Timaxian and
  • Gwendal Lazennec

27 July 2020

The tumor microenvironment appears essential in cancer progression and chemokines are mediators of the communication between cancer cells and stromal cells. We have previously shown that the ligands of the chemokine receptor CXCR2 were expressed at h...

  • Review
  • Open Access
128 Citations
16,131 Views
14 Pages

Involvement of CXCR4 in Normal and Abnormal Development

  • Nanako Kawaguchi,
  • Ting-Ting Zhang and
  • Toshio Nakanishi

20 February 2019

CXC motif chemokine receptor type 4 (CXCR4) is associated with normal and abnormal development, including oncogenesis. The ligand of CXCR4 is stromal cell-derived factor (SDF), also known as CXC motif ligand (CXCL) 12. Through the SDF-1/CXCR4 axis, b...

  • Article
  • Open Access
21 Citations
7,115 Views
18 Pages

Breast Cancer: An Examination of the Potential of ACKR3 to Modify the Response of CXCR4 to CXCL12

  • Irene del Molino del Barrio,
  • Georgina C. Wilkins,
  • Annette Meeson,
  • Simi Ali and
  • John A. Kirby

14 November 2018

Upon binding with the chemokine CXCL12, the chemokine receptor CXCR4 has been shown to promote breast cancer progression. This process, however, can be affected by the expression of the atypical chemokine receptor ACKR3. Given ACKR3’s ability to form...

  • Article
  • Open Access
1,799 Views
17 Pages

CXCR1 Expression in MDA-PCa-2b Cell Upregulates ITM2A to Inhibit Tumor Growth

  • Timothy O. Adekoya,
  • Nikia Smith,
  • Parag Kothari,
  • Monique A. Dacanay,
  • Yahui Li and
  • Ricardo M. Richardson

11 December 2024

Background: Chemokines, along with their receptors, exert critical roles in tumor development and progression. In prostate cancer (PCa), interleukin-8 (IL-8/CXCL8) was shown to enhance angiogenesis, proliferation, and metastasis. CXCL8 activates two...

  • Review
  • Open Access
34 Citations
4,719 Views
17 Pages

In Vivo Targeting of CXCR4—New Horizons

  • Margret Schottelius,
  • Ken Herrmann and
  • Constantin Lapa

25 November 2021

Given its pre-eminent role in the context of tumor cell growth as well as metastasis, the C-X-C motif chemokine receptor 4 (CXCR4) has attracted a lot of interest in the field of nuclear oncology, and clinical evidence on the high potential of CXCR4-...

  • Article
  • Open Access
18 Citations
5,722 Views
15 Pages

Differences in Sulfotyrosine Binding amongst CXCR1 and CXCR2 Chemokine Ligands

  • Natasha A. Moussouras,
  • Anthony E. Getschman,
  • Emily R. Lackner,
  • Christopher T. Veldkamp,
  • Michael B. Dwinell and
  • Brian F. Volkman

3 September 2017

Tyrosine sulfation, a post-translational modification found on many chemokine receptors, typically increases receptor affinity for the chemokine ligand. A previous bioinformatics analysis suggested that a sulfotyrosine (sY)-binding site on the surfac...

  • Article
  • Open Access
4 Citations
2,622 Views
16 Pages

Exploring the Interplay of RUNX2 and CXCR4 in Melanoma Progression

  • Luca Dalle Carbonare,
  • Arianna Minoia,
  • Anna Vareschi,
  • Francesca Cristiana Piritore,
  • Sharazed Zouari,
  • Alberto Gandini,
  • Mirko Meneghel,
  • Rossella Elia,
  • Pamela Lorenzi and
  • Maria Teresa Valenti
  • + 5 authors

27 February 2024

Overexpression of the Runt-related transcription factor 2 (RUNX2) has been reported in several cancer types, and the C-X-C motif chemokine receptor 4 (CXCR4) has an important role in tumour progression. However, the interplay between CXCR4 and RUNX2...

  • Article
  • Open Access
14 Citations
4,985 Views
53 Pages

Bioinformatic Analysis of the CXCR2 Ligands in Cancer Processes

  • Jan Korbecki,
  • Mateusz Bosiacki,
  • Dariusz Chlubek and
  • Irena Baranowska-Bosiacka

27 August 2023

Human CXCR2 has seven ligands, i.e., CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, and CXCL8/IL-8—chemokines with nearly identical properties. However, no available study has compared the contribution of all CXCR2 ligands to cancer progression. Tha...

  • Review
  • Open Access
10 Citations
7,592 Views
29 Pages

9 January 2022

The manifold actions of the pro-inflammatory and regenerative chemokine CXCL12/SDF-1α are executed through the canonical GProteinCoupledReceptor CXCR4, and the non-canonical ACKR3/CXCR7. Platelets express CXCR4, ACKR3/CXCR7, and are a vital sou...

  • Article
  • Open Access
20 Citations
5,333 Views
18 Pages

The CXCR4–CXCL12-Axis Is of Prognostic Relevance in DLBCL and Its Antagonists Exert Pro-Apoptotic Effects In Vitro

  • Katrin Pansy,
  • Julia Feichtinger,
  • Barbara Ehall,
  • Barbara Uhl,
  • Miriam Sedej,
  • David Roula,
  • Beata Pursche,
  • Axel Wolf,
  • Manuel Zoidl and
  • Alexander JA. Deutsch
  • + 10 authors

24 September 2019

In tumor cells of more than 20 different cancer types, the CXCR4-CXCL12-axis is involved in multiple key processes including proliferation, survival, migration, invasion, and metastasis. Since data on this axis in diffuse large B cell lymphoma (DLBCL...

  • Article
  • Open Access
17 Citations
4,732 Views
13 Pages

CXCR2: A Novel Mediator of Mammary Tumor Bone Metastasis

  • Bhawna Sharma,
  • Kalyan C. Nannuru,
  • Sugandha Saxena,
  • Michelle L. Varney and
  • Rakesh K. Singh

Most breast cancer patients die due to bone metastasis. Although metastasis accounts for 5% of the breast cancer cases, it is responsible for most of the deaths. Sometimes even before the detection of a primary tumor, most of the patients have bone a...

  • Review
  • Open Access
20 Citations
6,403 Views
21 Pages

12 June 2023

C-X-C chemokine receptor type 4 (CXCR4), also known as fusin or CD184, is a 7-transmembrane helix G-protein-coupled receptor that is encoded by the CXCR4 gene. Involved in various physiological processes, CXCR4 could form an interaction with its endo...

  • Article
  • Open Access
5 Citations
2,532 Views
16 Pages

Interleukin-8/CXCR1 Signaling Contributes to the Progression of Pulmonary Adenocarcinoma Resulting in Malignant Pleural Effusion

  • Yi-Ming Chang,
  • Wen-Yen Huang,
  • Shih-Hsien Yang,
  • Chia-Ing Jan,
  • Shin Nieh,
  • Yaoh-Shiang Lin,
  • Su-Feng Chen and
  • Yu-Chun Lin

3 June 2024

Pulmonary adenocarcinoma (PADC) treatment limited efficacy in preventing tumor progression, often resulting in malignant pleural effusion (MPE). MPE is filled with various mediators, especially interleukin-8 (IL-8). However, the role of IL-8 and its...

  • Article
  • Open Access
561 Views
16 Pages

Targeting CXCR6 Disrupts β-Catenin Signaling and Enhances Sorafenib Response in Hepatocellular Carcinoma

  • Morgan Reeves,
  • Anastasia Chambers,
  • Abhishek Shrestha,
  • Sergio Duarte,
  • Ali Zarrinpar,
  • Siobhan Malany and
  • Satyamaheshwar Peddibhotla

28 November 2025

Background/Objectives: Hepatocellular carcinoma (HCC) therapies are limited by poor response, rapid resistance, and recurrence of aggressive disease. Sorafenib, a multi-tyrosine kinase inhibitor, can trigger β-catenin stabilization and activatio...

  • Review
  • Open Access
29 Views
26 Pages

CXCR4: A Promising Novel Strategy for Lung Cancer Treatment

  • Mengting Liao,
  • Jianmin Wu,
  • Tengkun Dai,
  • Guiyan Liu,
  • Jiayi Zhang,
  • Yiling Zhu,
  • Lin Xu and
  • Juanjuan Zhao

26 January 2026

Lung cancer remains a major public health challenge due to high incidence and mortality. The chemokine receptor CXCR4 and its ligand CXCL12 (SDF-1) constitute a critical axis in tumor biology, influencing tumor cell proliferation, invasion, angiogene...

  • Review
  • Open Access
116 Citations
15,718 Views
21 Pages

CXCR2 Receptor: Regulation of Expression, Signal Transduction, and Involvement in Cancer

  • Jan Korbecki,
  • Patrycja Kupnicka,
  • Mikołaj Chlubek,
  • Jarosław Gorący,
  • Izabela Gutowska and
  • Irena Baranowska-Bosiacka

16 February 2022

Chemokines are a group of about 50 chemotactic cytokines crucial for the migration of immune system cells and tumor cells, as well as for metastasis. One of the 20 chemokine receptors identified to date is CXCR2, a G-protein-coupled receptor (GPCR) w...

  • Article
  • Open Access
2,167 Views
11 Pages

CXCR4 Expression as a Prognostic Biomarker in Soft Tissue Sarcomas

  • Anna C. Virgili,
  • Juliana Salazar,
  • Alberto Gallardo,
  • Antonio López-Pousa,
  • Raúl Terés,
  • Silvia Bagué,
  • Ruth Orellana,
  • Caterina Fumagalli,
  • Ramon Mangues and
  • Ana Sebio
  • + 3 authors

Poor long-term survival in localized high-risk soft tissue sarcomas (STSs) of the extremities and trunk highlights the need to identify new prognostic factors. CXCR4 is a chemokine receptor involved in tumor progression, angiogenesis, and metastasis....

  • Article
  • Open Access
5 Citations
3,422 Views
19 Pages

Discovery of Bis-Imidazoline Derivatives as New CXCR4 Ligands

  • Zhicheng Zhou,
  • Isabelle Staropoli,
  • Anne Brelot,
  • Peggy Suzanne,
  • Aurélien Lesnard,
  • Fanny Fontaine,
  • Serge Perato,
  • Sylvain Rault,
  • Olivier Helynck and
  • Philippe Colin
  • + 4 authors

24 January 2023

The chemokine receptor CXCR4 and its ligand CXCL12 regulate leukocyte trafficking, homeostasis and functions and are potential therapeutic targets in many diseases such as HIV-1 infection and cancers. Here, we identified new CXCR4 ligands in the CERM...

  • Article
  • Open Access
6 Citations
3,699 Views
14 Pages

An Evaluation of CXCR4 Targeting with PAMAM Dendrimer Conjugates for Oncologic Applications

  • Wojciech G. Lesniak,
  • Babak Behnam Azad,
  • Samit Chatterjee,
  • Ala Lisok and
  • Martin G. Pomper

The chemokine receptor 4 (CXCR4) is a promising diagnostic and therapeutic target for the management of various cancers. CXCR4 has been utilized in immunotherapy, targeted drug delivery, and endoradiotherapy. Poly(amidoamine) [PAMAM] dendrimers are w...

  • Article
  • Open Access
21 Citations
6,356 Views
15 Pages

CXCR4 Cardiac Specific Knockout Mice Develop a Progressive Cardiomyopathy

  • Thomas J. LaRocca,
  • Perry Altman,
  • Andrew A. Jarrah,
  • Ron Gordon,
  • Edward Wang,
  • Lahouaria Hadri,
  • Mark W. Burke,
  • Georges E. Haddad,
  • Roger J. Hajjar and
  • Sima T. Tarzami

Activation of multiple pathways is associated with cardiac hypertrophy and heart failure. We previously published that CXCR4 negatively regulates β-adrenergic receptor (β-AR) signaling and ultimately limits β-adrenergic diastolic (Ca2+...

  • Article
  • Open Access
7 Citations
4,722 Views
18 Pages

CXCR4-CCR7 Heterodimerization Is a Driver of Breast Cancer Progression

  • Valentina Poltavets,
  • Jessica W. Faulkner,
  • Deepak Dhatrak,
  • Robert J. Whitfield,
  • Shaun R. McColl and
  • Marina Kochetkova

7 October 2021

Metastatic breast cancer has one of the highest mortality rates among women in western society. Chemokine receptors CXCR4 and CCR7 have been shown to be linked to the metastatic spread of breast cancer, however, their precise function and underlying...

  • Article
  • Open Access
11 Citations
3,274 Views
19 Pages

Divergent Expression Patterns and Function of Two cxcr4 Paralogs in Hermaphroditic Epinephelus coioides

  • Wei-Jia Lu,
  • Li Zhou,
  • Fan-Xiang Gao,
  • Zhi-Hui Sun,
  • Zhi Li,
  • Xiao-Chun Liu,
  • Shui-Sheng Li,
  • Yang Wang and
  • Jian-Fang Gui

27 September 2018

Chemokine receptor Cxcr4 evolved two paralogs in the teleost lineage. However, cxcr4a and cxcr4b have been characterized only in a few species. In this study, we identified two cxcr4 paralogs from the orange-spotted grouper, Epinephelus coioides. The...

  • Article
  • Open Access
12 Citations
4,273 Views
18 Pages

D-Peptide-Based Probe for CXCR4-Targeted Molecular Imaging and Radionuclide Therapy

  • Kaat Luyten,
  • Tom Van Loy,
  • Christopher Cawthorne,
  • Christophe M. Deroose,
  • Dominique Schols,
  • Guy Bormans and
  • Frederik Cleeren

Positron emission tomography (PET) imaging of the C-X-C chemokine receptor 4 (CXCR4) with [68Ga]PentixaFor has intrinsic diagnostic value and is used to select patients for personalized CXCR4-targeted radionuclide therapy with its therapeutic radioph...

  • Article
  • Open Access
1 Citations
2,762 Views
9 Pages

2 May 2022

Some viruses contain mimics of host chemokine receptors that influence host immunity; however, such viral mimics have not yet been reported for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In this study, I focused on C-X-C motif chem...

  • Article
  • Open Access
32 Citations
5,971 Views
20 Pages

Pivotal Role for Cxcr2 in Regulating Tumor-Associated Neutrophil in Breast Cancer

  • Colin Timaxian,
  • Christoph F. A. Vogel,
  • Charlotte Orcel,
  • Diana Vetter,
  • Camille Durochat,
  • Clarisse Chinal,
  • Phuong NGuyen,
  • Marie-Laure Aknin,
  • Françoise Mercier-Nomé and
  • Gwendal Lazennec
  • + 8 authors

25 May 2021

Chemokines present in the tumor microenvironment are essential for the control of tumor progression. We show here that several ligands of the chemokine receptor Cxcr2 were up-regulated in the PyMT (polyoma middle T oncogene) model of breast cancer. I...

  • Review
  • Open Access
27 Citations
3,397 Views
11 Pages

The Role of Chemokine Receptor CXCR3 and Its Ligands in Renal Cell Carcinoma

  • Monika Gudowska-Sawczuk,
  • Jacek Kudelski and
  • Barbara Mroczko

14 November 2020

The major invasive subtype of kidney cancer is renal cell carcinoma (RCC). The essential components of cancer development are chronic inflammation and neoangiogenesis. It has been suggested that the chemokine ligand 9, -10, –11 (CXCL9–11)...

  • Article
  • Open Access
33 Citations
5,672 Views
16 Pages

CXCL1/CXCR2 Paracrine Axis Contributes to Lung Metastasis in Osteosarcoma

  • Chia-Chia Chao,
  • Chiang-Wen Lee,
  • Tsung-Ming Chang,
  • Po-Chun Chen and
  • Ju-Fang Liu

17 February 2020

Osteosarcoma, the most common of all bone malignancies, has a high likelihood of lung metastasis. Up until now, the molecular mechanisms involved in osteosarcomas with lung metastases are not clearly understood. Recent observations have shown that th...

  • Article
  • Open Access
10 Citations
3,510 Views
16 Pages

Inhibition of CXCR4 Enhances the Efficacy of Radiotherapy in Metastatic Prostate Cancer Models

  • Nisha Gupta,
  • Hiroki Ochiai,
  • Yoshinori Hoshino,
  • Sebastian Klein,
  • Jozef Zustin,
  • Rakesh R. Ramjiawan,
  • Shuji Kitahara,
  • Nir Maimon,
  • Despina Bazou and
  • Dan G. Duda
  • + 7 authors

6 February 2023

Radiotherapy (RT) is a standard treatment for patients with advanced prostate cancer (PCa). Previous preclinical studies showed that SDF1α/CXCR4 axis could mediate PCa metastasis (most often to the bones) and cancer resistance to RT. We found h...

  • Review
  • Open Access
18 Citations
5,388 Views
22 Pages

Crosstalk between CXCL12/CXCR4/ACKR3 and the STAT3 Pathway

  • Zelong Ma,
  • Faxiao Zhou,
  • Hua Jin and
  • Xiaoming Wu

13 June 2024

The reciprocal modulation between the CXCL12/CXCR4/ACKR3 axis and the STAT3 signaling pathway plays a crucial role in the progression of various diseases and neoplasms. Activation of the CXCL12/CXCR4/ACKR3 axis triggers the STAT3 pathway through mult...

  • Article
  • Open Access
12 Citations
5,445 Views
16 Pages

[18F]Fluoroethyltriazolyl Monocyclam Derivatives as Imaging Probes for the Chemokine Receptor CXCR4

  • Alejandro Amor-Coarasa,
  • James M. Kelly,
  • Pradeep K. Singh,
  • Shashikanth Ponnala,
  • Anastasia Nikolopoulou,
  • Clarence Williams,
  • Yogindra Vedvyas,
  • Moonsoo M. Jin,
  • J. David Warren and
  • John W. Babich

24 April 2019

Determining chemokine receptor CXCR4 expression is significant in multiple diseases due to its role in promoting inflammation, cell migration and tumorigenesis. [68Ga]Pentixafor is a promising ligand for imaging CXCR4 expression in multiple tumor typ...

  • Article
  • Open Access
16 Citations
3,501 Views
17 Pages

Biparatopic Protein Nanoparticles for the Precision Therapy of CXCR4+ Cancers

  • Olivia Cano-Garrido,
  • Patricia Álamo,
  • Laura Sánchez-García,
  • Aïda Falgàs,
  • Alejandro Sánchez-Chardi,
  • Naroa Serna,
  • Eloi Parladé,
  • Ugutz Unzueta,
  • Mònica Roldán and
  • Esther Vázquez
  • + 4 authors

11 June 2021

The accumulated molecular knowledge about human cancer enables the identification of multiple cell surface markers as highly specific therapeutic targets. A proper tumor targeting could significantly avoid drug exposure of healthy cells, minimizing s...

  • Review
  • Open Access
6 Citations
3,697 Views
14 Pages

CXCR4: From Signaling to Clinical Applications in Neuroendocrine Neoplasms

  • David Sanchis-Pascual,
  • María Isabel Del Olmo-García,
  • Stefan Prado-Wohlwend,
  • Carlos Zac-Romero,
  • Ángel Segura Huerta,
  • Javier Hernández-Gil,
  • Luis Martí-Bonmatí and
  • Juan Francisco Merino-Torres

8 May 2024

There are several well-described molecular mechanisms that influence cell growth and are related to the development of cancer. Chemokines constitute a fundamental element that is not only involved in local growth but also affects angiogenesis, tumor...

  • Article
  • Open Access
1,019 Views
25 Pages

CXCR5 Signals Fine-Tune Dendritic Cell Transcription and Regulate TH2 Development

  • Miranda L. Curtiss,
  • Natalia Ballesteros Benavides,
  • Alexander F. Rosenberg,
  • Christopher D. Scharer,
  • Beatriz León and
  • Frances E. Lund

3 September 2025

Background/Objectives: We previously demonstrated that dendritic cell (DC) expression of CXCR5 is required for TH2 priming in mice infected with the helminth Heligmosomoides polygyrus (Hp). In this manuscript we examined how CXCR5 controls DC mediate...

  • Article
  • Open Access
2 Citations
2,603 Views
20 Pages

New Emerging Chemokine Receptors: CCR5 or CXCR5 on Tumor Is Associated with Poor Response to Chemotherapy and Poor Prognosis in Locally Advanced Triple-Negative Breast Cancer

  • Neslihan Cabioglu,
  • Semen Onder,
  • Hüseyin Karatay,
  • Aysel Bayram,
  • Gizem Oner,
  • Mustafa Tukenmez,
  • Mahmut Muslumanoglu,
  • Abdullah Igci,
  • Ahmet Dinccag and
  • Ekrem Yavuz
  • + 3 authors

28 June 2024

Background: We aim to investigate any possible associations between chemokine receptor expression and responses to neoadjuvant chemotherapy (NAC) along with outcomes in patients with triple-negative breast cancer (TNBC) with locally advanced disease....

  • Article
  • Open Access
2 Citations
3,501 Views
28 Pages

Exploration of Pyrido[3,4-d]pyrimidines as Antagonists of the Human Chemokine Receptor CXCR2

  • Max Van Hoof,
  • Sandra Claes,
  • Katrijn Boon,
  • Tom Van Loy,
  • Dominique Schols,
  • Wim Dehaen and
  • Steven De Jonghe

23 February 2023

Upregulated CXCR2 signalling is found in numerous inflammatory, autoimmune and neurodegenerative diseases, as well as in cancer. Consequently, CXCR2 antagonism is a promising therapeutic strategy for treatment of these disorders. We previously identi...

  • Review
  • Open Access
93 Citations
12,911 Views
13 Pages

CXCR4/CXCL12 Activities in the Tumor Microenvironment and Implications for Tumor Immunotherapy

  • Rosanna Mezzapelle,
  • Manuela Leo,
  • Francesca Caprioglio,
  • Liam S. Colley,
  • Andrea Lamarca,
  • Lina Sabatino,
  • Vittorio Colantuoni,
  • Massimo P. Crippa and
  • Marco E. Bianchi

6 May 2022

CXCR4 is a G-Protein coupled receptor that is expressed nearly ubiquitously and is known to control cell migration via its interaction with CXCL12, the most ancient chemokine. The functions of CXCR4/CXCL12 extend beyond cell migration and involve the...

  • Article
  • Open Access
25 Citations
7,437 Views
13 Pages

CXCR4 is a crucial chemokine receptor that plays key roles in primordial germ cell (PGC) homing. To further characterize the CXCR4-mediated migration of PGCs, we screened CXCR4-interacting proteins using yeast two-hybrid screening. We identified reti...

  • Article
  • Open Access
9 Citations
8,248 Views
15 Pages

Development of a Novel SPR Assay to Study CXCR4–Ligand Interactions

  • Arnaud Boonen,
  • Abhimanyu K. Singh,
  • Anneleen Van Hout,
  • Kalyan Das,
  • Tom Van Loy,
  • Sam Noppen and
  • Dominique Schols

21 October 2020

G protein-coupled receptors (GPCRs) are involved in a plethora of different diseases. Consequently, these proteins are considered as an important class of drug targets. Measuring detailed kinetic information on these types of proteins has been challe...

  • Article
  • Open Access
5 Citations
5,735 Views
12 Pages

The Impact of CXCR4 Blockade on the Survival of Rat Brain Cortical Neurons

  • José Joaquín Merino,
  • Alba Garcimartín,
  • María Elvira López-Oliva,
  • Juana Benedí and
  • María Pilar González

30 November 2016

Background: Chemokine receptor type 4 (CXCR4) plays a role in neuronal survival/cell repair and also contributes to the progression of cancer and neurodegenerative diseases. Chemokine ligand 12 (CXCL12) binds to CXCR4. In this study, we have investig...

  • Article
  • Open Access
15 Citations
2,989 Views
12 Pages

Prognostic Significance of CXCR4 in Colorectal Cancer: An Updated Meta-Analysis and Critical Appraisal

  • Alessandro Ottaiano,
  • Mariachiara Santorsola,
  • Paola Del Prete,
  • Francesco Perri,
  • Stefania Scala,
  • Michele Caraglia and
  • Guglielmo Nasti

30 June 2021

Background: This study was conducted to provide an updated estimate of the prognostic power of C-X-C chemokine receptor type 4 (CXCR4) in colorectal cancer (CRC), and analyze modalities of evaluating and reporting its expression. Methods: A systemati...

  • Article
  • Open Access
3 Citations
1,478 Views
13 Pages

The Role of CXCR2, MMP-2, and MMP-9 in the Pathogenesis of Placenta Accreta: A Molecular Expression Study

  • Putri Mirani,
  • Krisna Murti,
  • Peby Maulina Lestari,
  • Iche Andriyani Liberty,
  • Cindy Kesty,
  • Hana Andrina and
  • Bella Stevanny

6 March 2025

Background and Objectives: The pathogenesis of placenta accreta spectrum disorder (PASD) is influenced by the inflammatory process. Therefore, the examination of biomarkers related to the inflammatory process, namely matrix metalloproteinase (MMP) an...

of 19